Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-17 · accession 0001213900-23-041642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-19 | 2023-05-17 | OBIO | ROSE ERIC A MD | Dir | F - Tax | $16.04 | -157 | 2,168 | -7% | -$2,518 |
| D | 2023-05-19 | 2023-05-17 | OBIO | ROSE ERIC A MD | Dir | M - OptEx | $1.08 | +2,325 | 2,325 | New | +$2,511 |
| D | 2023-05-19 | 2023-05-17 | OBIO | ROSE ERIC A MD | Dir | M - OptEx | $0.00 | -2,325 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | F | D | 157 | $16.04 | 2,168 | D | — | — | (F2) Represents the shares of Common Stock deemed withheld by the Issuer in connection with the cashless exercise. (F3) Pursuant to Section 3(c) of the warrant, the price was calculated as the average closing price per share of Common Stock for the 20 trading days immediately preceding the date on which the notice of exercise was deemed to have been sent to the Issuer. |
| 2 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2023-05-17 | M | A | 2,325 | $1.08 | 2,325 | D | — | — | |
| 3 | Derivative | Warrant (Right to Buy) | 2023-05-17 | M | D | 2,325 | $0.00 | 0 | D | $1.08 · 2023-01-26 to 2023-05-31 | 2,325 Common Stock |